Summary Stage 2018: Larynx (excluding Melanoma [8720-8790])

Summary Stage 2018

Notes

**Larynx Other** C323, C328-C329 C323 Laryngeal cartilage C328 Overlapping lesion of larynx C329 Larynx, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 13 *Larynx*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** Impaired vocal cord mobility, also described as vocal cord paresis, may suggest invasion of intrinsic laryngeal muscle. Fixation of the vocal cord may be described as immobility of the arytenoids noted on endoscopy, vocal cord paralysis, or deviation of larynx to fixed side. **Note 3:** Code 1 for localized tumor only if no information is available to identify further extension.

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ: noninvasive, intraepithelial
1 Localized only (localized, NOS) - Confined to larynx, NOS - Involvement adjacent regions(s) of larynx WITH normal or impaired mobility + Glottis + Supraglottis - Limited to larynx with vocal cord fixation
2 Regional by direct extension only - Base of tongue - Hypopharynx, NOS - Paraglottic space - Postcricoid area - Pre-epiglottic tissues - Pyriform sinus (pyriform fossa) - Thyroid cartilage (inner cortex) - Vallecula
3 Regional lymph node(s) involved only - Level I + Level IA - Submental + Level IB - Submandibular (submaxillary), sublingual - Level II - Upper jugular + Jugulodigastric (subdigastric) + Upper deep cervical + Level IIA - Anterior + Level IIB - Posterior - Level III - Middle jugular + Middle deep cervical - Level IV - Lower jugular + Jugulo-omohyoid (supraomohyoid) + Lower deep cervical + Virchow node - Level V - Posterior triangle group + Posterior cervical + Level VA - Spinal accessory + Level VB - Transverse cervical, supraclavicular - Level VI - Anterior compartment group + Laterotracheal + Paralaryngeal + Paratracheal - above suprasternal notch + Perithyroidal + Precricoid (Delphian) + Prelaryngeal + Pretracheal - above suprasternal notch + Recurrent laryngeal - Level VII - Superior mediastinal group (for other mediastinal node(s) see code 7) + Esophageal groove + Paratracheal - below suprasternal notch + Pretracheal - below suprasternal notch - Other groups + Cervical, NOS + Deep cervical, NOS + Facial * Buccinator (buccal) * Mandibular * Nasolabial + Internal jugular, NOS + Parapharyngeal + Parotid * Infraauricular * Intraparotid * Periparotid * Preauricular + Retroauricular (mastoid) + Retropharyngeal + Suboccipital - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Carotid artery (encased) + Cricoid cartilage + Esophagus + Extrinsic muscle(s) of tongue * Genioglossus * Geniohyoid * Hyoglossus * Mylohyoid * Palatoglossus * Styloglossus + Mediastinal structure(s) + Oropharynx + Prevertebral space + Skin + Soft tissues of neck + Strap muscle(s) * Omohyoid * Sternohyoid * Sternothyroid * Thyrohyoid + Thyroid cartilage (outer cortex, NOS) + Thyroid gland + Trachea - Distant lymph node(s), NOS + Mediastinal (excluding superior mediastinal node(s)) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Lydiatt, W.M., Patel, S.G., Shah, J.P., et al. **Staging Head and Neck Cancers**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 55-65 (6) Patel, S.G., Lydiatt, W.M., Shah, J.P., et al. **Larynx**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 149-161